RAC1 P29S regulates PD-L1 expression in melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RAC1 P29S regulates PD-L1 expression in melanoma

Published:2015-08-16 Issue:5 Volume:28 Page:590-598
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res

Author:

Vu Ha Linh¹,Rosenbaum Sheera¹,Purwin Timothy J.¹,Davies Michael A.²,Aplin Andrew E.¹³

Affiliation:

1. Department of Cancer Biology and Sidney Kimmel Cancer Center; Thomas Jefferson University; Philadelphia PA USA

2. Division of Cancer Medicine; Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston TX USA

3. Department of Dermatology and Cutaneous Biology; Thomas Jefferson University; Philadelphia PA USA

Funder

National Institutes of Health

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

National Cancer Institute Support

NCI Cancer Center Support

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12392/fullpdf

Reference36 articles.

1. FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells;Abel;Cancer Res.,2010

2. Atkins , M.B. Kudchadkar , R.R. Sznol , M. 2014 Phase 2, multicenter, safety and efficacy study of pidilizumab in patients with metastatic melanoma

3. Restoring function in exhausted CD8 T cells during chronic viral infection;Barber;Nature,2006

4. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth;Bennett;Int. J. Cancer,1987

5. RAC1: An emerging therapeutic option for targeting cancer angiogenesis and metastasis;Bid;Mol. Cancer Ther.,2013

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RHOF activation of AKT/β-catenin signaling pathway drives acute myeloid leukemia progression and chemotherapy resistance;iScience;2024-07

2. RAC1 as a potential pan-cancer diagnostic, prognostic, and immunological biomarker;Translational Cancer Research;2024-03

3. Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints;Oncogene;2024-01-19

4. PAK1 and Therapy Resistance in Melanoma;Cells;2023-09-28

5. Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints;2023-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3